MAGY Only Makes Sense If You Already Own The Underlying
seekingalpha.com
Want to monitor AKBA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor AKBAakebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients.